Company news
Biostax Corp. news in 2014
Biostax Corp.'s news releases, calls and decks from 2014, newest first.
TNI BioTech, Inc. through its wholly owned subsidiary TNI BioTech International Ltd., provides progress report on bridging trial for HIV/AIDS in Nigeria
December 4, 2014
TNI BioTech, Inc. Provides Extension of Delivery of Shares to the Transfer Agent
December 1, 2014
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS
October 30, 2014
TNIB announced a spin-off of restricted shares of Cytocom, Inc with a record date of 9/30/2014. TNIB will not be quoted ex-dividend
September 30, 2014
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend
September 29, 2014
TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible
September 23, 2014
TNI BioTech Announces Results of Annual Shareholders Meeting
September 9, 2014
TNI BioTech Inc. Announces First Shipment of Lodonal® to The Republic of Panama and The Republic of Malawi
August 27, 2014
TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014
August 18, 2014
TNI BioTech, Inc., Announces an Extension to the Record Date of its wholly owned subsidiary, Cytocom Inc., and Dividend now Set for September 30, 2014
August 14, 2014
TNI BioTech and Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement
August 13, 2014
TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card
July 28, 2014
TNI BioTech, Inc. Establishes New Record Date for Spin-Off Stock Dividend of Cytocom, Inc. Shares
July 14, 2014
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa - CORRECTION
June 25, 2014
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa
June 25, 2014
TNI BioTech, Inc. Cancels Proposed Reverse Split of its Common Stock
June 24, 2014
TNI BioTech, Inc. Files Schedule 14A and Announces Annual Meeting
June 18, 2014
TNI BioTech, Inc. Obtains Drug Approval For Sale of Low Dose Naltrexone (LDN) From Government of Malawi
May 6, 2014
TNI BioTech, Inc. Announces Proposed Spin-Off of Cytocom, Inc.
May 1, 2014
TNI BioTech, Inc. Announces Further Agreement on Methionine-Enkephalin with Hubei Qianjiang Pharmaceutical Co., Ltd.
March 26, 2014
TNI BioTech, Inc. Granted Additional Patent for Methods for Inducing Sustained Immune Response of T-Cells
March 12, 2014
The Brewer Group Announces Strategic Partnership with TNI BioTech, Inc.
March 7, 2014
TNI BioTech, Inc. Forms New Subsidiary, Cytocom Inc., to develop LDN and MENK
March 6, 2014
TNI BIOTECH Announces SEC Clearance Of Form 10 Registration Statement And Clears Way To Upgrade To A Higher Exchange
February 11, 2014